UPDATED May 31, 2024
Discover U.S. Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
YTRA | US$1.28 | -19.5% | -40.5% | US$98.1m | US$4.00 | PS1.5x | E207.1% | n/a | Consumer Services | ||
RVAC | US$11.15 | 11.2% | n/a | US$348.4m | US$14.50 | PE-83x | E198.4% | n/a | Diversified Financials | ||
AVTA | US$25.99 | 0.2% | 6.2% | US$957.1m | US$28.00 | PE4003.1x | E184.1% | n/a | Diversified Financials | ||
LTRX | US$3.98 | 6.1% | -5.9% | US$145.4m | US$7.60 | PS1x | E174.9% | n/a | Tech | ||
MGNI | US$12.34 | -1.8% | -7.1% | US$1.7b | US$16.06 | PS2.7x | E172.2% | n/a | Media | ||
EXPI | US$11.21 | -0.3% | -30.0% | US$1.7b | US$11.58 | PB7.8x | E171.2% | 1.8% | Real Estate Management and Development | ||
SBFM | US$0.63 | -17.0% | -99.1% | US$12.4m | US$15.00 | PB0.5x | E171.1% | n/a | Pharmaceuticals & Biotech | ||
ARI | US$10.10 | -0.7% | -5.9% | US$1.4b | US$10.00 | PS10.6x | E170.0% | 13.9% | Diversified Financials | ||
CMTG | US$7.89 | 8.5% | -26.7% | US$1.1b | US$9.00 | PS25x | E167.9% | 12.7% | Diversified Financials | ||
QRHC | US$8.84 | -5.2% | 52.7% | US$183.7m | US$14.00 | PB2.7x | E167.9% | n/a | Commercial Services | ||
RMAX | US$8.09 | -1.6% | -57.4% | US$251.0m | US$9.00 | PB0.4x | E167.7% | 0% | Real Estate Management and Development | ||
MATV | US$17.97 | -4.0% | 12.7% | US$999.5m | US$24.50 | PB1.1x | E167.1% | 2.2% | Materials | ||
FET | US$18.24 | -0.5% | -24.0% | US$221.4m | n/a | PB0.5x | E167.1% | n/a | Energy | ||
HTLD | US$11.32 | -1.7% | -29.7% | US$894.1m | US$12.20 | PB1.1x | E166.8% | 0.7% | Transportation | ||
IVDA | US$0.68 | 5.7% | -41.6% | US$11.0m | US$1.50 | PS2.4x | E165.5% | n/a | Software | ||
OLK | US$23.95 | -0.08% | 20.3% | US$3.0b | US$26.00 | PS17.4x | E165.4% | n/a | Pharmaceuticals & Biotech | ||
PBI | US$5.42 | 3.2% | 55.7% | US$955.2m | US$6.00 | PE-2.5x | E163.7% | 3.7% | Commercial Services | ||
CTNT | US$0.77 | -12.5% | n/a | US$28.7m | n/a | PB3.5x | E163.5% | n/a | Retail | ||
ACRE | US$6.96 | 6.3% | -27.4% | US$370.0m | US$7.20 | PS10.4x | E162.5% | 14.4% | Diversified Financials | ||
BTM | US$1.99 | -2.5% | -80.8% | US$116.5m | US$4.56 | PE-1x | E162.2% | n/a | Commercial Services | ||
AJX | US$3.39 | 1.8% | -40.5% | US$119.8m | US$6.00 | PB0.5x | E162.0% | 7.1% | Diversified Financials | ||
BKTI | US$13.26 | -4.5% | -1.8% | US$48.4m | US$20.00 | PB2.2x | E161.7% | 0% | Tech | ||
UCTT | US$46.38 | 2.8% | 34.8% | US$2.1b | US$54.33 | PS1.2x | E161.3% | n/a | Semiconductors | ||
MHH | US$8.01 | -1.7% | -20.5% | US$93.3m | US$15.50 | PB1.1x | E161.1% | n/a | Commercial Services |